These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

859 related articles for article (PubMed ID: 6561202)

  • 41. Regulation of the coagulant activity and surface binding of high molecular weight kininogen.
    Colman RW; Silver LD; Purdon AD; Chang JJ; Scott CF
    Trans Assoc Am Physicians; 1984; 97():113-23. PubMed ID: 6336014
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The relative amidolytic activity of Hageman factor (factor XII) and its fragments. The effect of high-molecular-weight kininogen and kaolin.
    Ratnoff OD
    J Lab Clin Med; 1980 Aug; 96(2):267-77. PubMed ID: 7400662
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Protein-protein interactions in contact activation of blood coagulation. Binding of high molecular weight kininogen and the 5-(iodoacetamido) fluorescein-labeled kininogen light chain to prekallikrein, kallikrein, and the separated kallikrein heavy and light chains.
    Bock PE; Shore JD; Tans G; Griffin JH
    J Biol Chem; 1985 Oct; 260(23):12434-43. PubMed ID: 3850090
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Identification of prekallikrein and high-molecular-weight kininogen as a complex in human plasma.
    Mandle RJ; Colman RW; Kaplan AP
    Proc Natl Acad Sci U S A; 1976 Nov; 73(11):4179-83. PubMed ID: 1069308
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Accelerating effect of zinc ions on the surface-mediated activation of factor XII and prekallikrein.
    Shimada T; Kato H; Iwanaga S
    J Biochem; 1987 Oct; 102(4):913-21. PubMed ID: 3436959
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of surfaces on fluid-phase prekallikrein activation.
    Scott CF; Kirby EP; Schick PK; Colman RW
    Blood; 1981 Mar; 57(3):553-60. PubMed ID: 6906235
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Surface activation of blood coagulation, fibrinolysis and kinin formation.
    Heimark RL; Kurachi K; Fujikawa K; Davie EW
    Nature; 1980 Jul; 286(5772):456-60. PubMed ID: 6447254
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A new assay for high molecular weight kininogen in human plasma using a chromogenic substrate.
    Scott CF; Pixley RA; Colman RW
    Thromb Res; 1987 Dec; 48(6):685-700. PubMed ID: 3501619
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human high molecular weight kininogen. Studies of structure-function relationships and of proteolysis of the molecule occurring during contact activation of plasma.
    Kerbiriou DM; Griffin JH
    J Biol Chem; 1979 Dec; 254(23):12020-7. PubMed ID: 500690
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A different cleavage site for high molecular weight kininogen in vivo following intravenous injection of dextran sulfate in the rabbit.
    Wiggins RC
    Circ Res; 1986 Apr; 58(4):595-604. PubMed ID: 2421941
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman Factor).
    Cochrane CG; Wuepper KD
    J Exp Med; 1971 Oct; 134(4):986-1004. PubMed ID: 4106492
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Fujiwara trait: the first case of kininogen deficiency in Japan.
    Oh-Ishi S; Ueno A; Uchida Y; Katori M; Hayashi H; Koya H; Kitajima K; Kimura I
    Adv Exp Med Biol; 1979; 120B():93-9. PubMed ID: 517263
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies on human high molecular weight (HMW) kininogen. III. Cleavage of HMW kininogen by the action of human salivary kallikrein.
    Mori K; Sakamoto W; Nagasawa S
    J Biochem; 1981 Aug; 90(2):503-9. PubMed ID: 6913579
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Kininogen deficiency in Fitzgerald trait: role of high molecular weight kininogen in clotting and fibrinolysis.
    Donaldson VH; Glueck HI; Miller MA; Movat HZ; Habal F
    J Lab Clin Med; 1976 Feb; 87(2):327-37. PubMed ID: 1245795
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Contact-activated fibrinolysis: role of surface concentration and high-molecular-weight kininogen.
    Goldsmith GH
    J Lab Clin Med; 1980 Aug; 96(2):222-31. PubMed ID: 7400661
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The autoactivation of rabbit Hageman factor.
    Wiggins RC; Cochrane CC
    J Exp Med; 1979 Nov; 150(5):1122-33. PubMed ID: 501286
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The mechanism by which the light chain of cleaved HMW-kininogen augments the activation of prekallikrein, factor XI and Hageman factor.
    Silverberg M; Nicoll JE; Kaplan AP
    Thromb Res; 1980 Oct; 20(2):173-89. PubMed ID: 6908319
    [No Abstract]   [Full Text] [Related]  

  • 58. Alteration of factor VII activity by activated Fletcher factor (a plasma kallikrein): a potential link between the intrinsic and extrinsic blood-clotting systems.
    Saito H; Ratnoff OD
    J Lab Clin Med; 1975 Mar; 85(3):405-15. PubMed ID: 234996
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prekallikrein activation by Hageman factor: potentiation by proteins in the absence of high molecular weight kininogen.
    Colman RW; Scott CF; Shames PV; Dayal V; Liu CY; Kirby EP
    Trans Assoc Am Physicians; 1979; 92():208-17. PubMed ID: 317690
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Factor XII-independent activation of the bradykinin-forming cascade: Implications for the pathogenesis of hereditary angioedema types I and II.
    Joseph K; Tholanikunnel BG; Bygum A; Ghebrehiwet B; Kaplan AP
    J Allergy Clin Immunol; 2013 Aug; 132(2):470-5. PubMed ID: 23672780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 43.